Category: Health Science
-
![Cybin (CYBN.NE) demonstrates Proof of Concept on CYB003 and CYB004 psychedelic molecules]()
Cybin (CYBN.NE) demonstrates Proof of Concept on CYB003 and CYB004 psychedelic molecules
Cybin (CYBN.NE) announced that they have successfully demonstrated Proof of Concept for their deuterated tryptamine programs, CYB003 and CYB004. The Proof of Concept revolves around the duration of psilocybin. A normal psilocybin experience will last around six hours, and can take up to an hour to begin. However, in their press release, Cybin notes that…
-
![Core One Labs (COOL.C) begins work on proprietary DMT production]()
Core One Labs (COOL.C) begins work on proprietary DMT production
Core One Labs’ (COOL.C) wholly-owned subsidiary Vocan Biotechnologies has initiated the design and engineering of a proprietary enzymatic production system for API-grade N,N-dimethyltryptamine, commonly known as DMT. DMT, also known as the “spirit molecule”, is a naturally occurring psychedelic and is an active component in ayahuasca. It plays an important role in various rites of…
-
![Sixth Wave Innovations (SIXW.C) Enters LOI With Halucenex Life Sciences]()
Sixth Wave Innovations (SIXW.C) Enters LOI With Halucenex Life Sciences
Sixth Wave Innovations (SIXW.C) entered into a non-binding letter of intent (LOI) with Halucenex Life Sciences, a soon to be wholly-owned subsidiary of Cresco Pharma. According to the terms outlined in the LOI, Sixth Wave will utilize its Affinity™ in collaboration with Halucenex to explore the separation of compounds such as psilocybin, baeocystin, and others…
-
![Cybin (CYBN.NE) establishes Clinical Advisory Board as they gear up for trials]()
Cybin (CYBN.NE) establishes Clinical Advisory Board as they gear up for trials
Cybin (CYBN.NE) announced they are forming a Clinical Advisory Board, which will be chaired by Alex Belser, Cybin’s Chief Clinical Officer. The board will consist of Belser (PhD), Maurizio Fava (MD), Lynn Marie Morski (DM) and Anthony Back (MD). All members of the board have professional experience in either medicine or research. Fava, the Psychiatrist-in-Chief…
-
Ortho Regenerative (ORTH.C) targets Q2, 2021 FDA clinical trials to improve surgical outcomes for soft tissue repairs
“2021 will be transformational for the company as we advance the clinical development of our lead product,” added LeDuc.
-
![Predictmedix (PMED.C) Enters Partnership with Juiceworks and Connectus for Safe Entry Stations]()
Predictmedix (PMED.C) Enters Partnership with Juiceworks and Connectus for Safe Entry Stations
Predictmedix (PMED.C) announced they are partnering with Juiceworks Exhibits and Connectus Global to deploy their Safe Entry Stations across the country. The Safe Entry Stations will use military-grade multispectral imaging, which captures things not immediately visible to the human eye. These multispectral cameras will be paired with Predictmedix’s proprietary, clinically based artificial intelligence algorithms which…
-
![Perimeter Medical Imaging AI (PINK.V) latest study is the latest assault in the war on cancer]()
Perimeter Medical Imaging AI (PINK.V) latest study is the latest assault in the war on cancer
More than terrorism, drugs, racial animus and acts of God, cancer has always been with us. It’s humanity’s number one enemy throughout history—it’s only recently that we’ve learned what little we know, and devised rudimentary strategies on how to secure its defeat. The statistics are harrowing. Do a headcount next time during your commute then…
-
![Predictmedix (PMED.C) engages global investment bank to prep for NASDAQ listing]()
Predictmedix (PMED.C) engages global investment bank to prep for NASDAQ listing
The Nasdaq Exchange has 3,300 listed stocks including giants such as Apple (AAPL.Q), Google (GOOG.Q), Microsoft (MSFT.Q), Oracle (ORCL.Q), Amazon (AMZN.Q), and Intel (INTC.Q).
-
Parry Special: Short report on Mountain Valley MD Holdings (MVMD.C) earns nothing but rage
When a ‘devastating’ expose on a company opens with the line ‘We are short this company’, I have to say, I find it hard to read much further. To open the discussion admitting you’ll make more money if the company you’re writing about gets obliterated, and then proceed to map out your obliteration strategy, well…
-
![Diagnos (ADK.V) uses AI and telemedicine to scan your eye for health issues in 16 countries]()
Diagnos (ADK.V) uses AI and telemedicine to scan your eye for health issues in 16 countries
In a world where companies toss the term ‘artificial intelligence’ around whenever the office intern figures out how to get a spreadsheet pie chart to update automatically, it’s nice to see a company utilizing actual AI and machine learning in a manner that involves actual intelligence and learning. Diagnos (ADK.V) is a health tech deal…
